NCT04262466 2026-03-06
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
Immunocore Ltd
Phase 1/2 Active not recruiting
Immunocore Ltd
European Organisation for Research and Treatment of Cancer - EORTC
University of Pittsburgh
Immunocore Ltd
Sarcoma Alliance for Research through Collaboration
H. Lee Moffitt Cancer Center and Research Institute
University of Oxford
DynamiCure Biotechnology
Immunocore Ltd
Immunocore Ltd
Immunocore Ltd